• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关注海洋动物安全和海洋生物资源,以应对 SARS-CoV-2 危机。

Focus on Marine Animal Safety and Marine Bioresources in Response to the SARS-CoV-2 Crisis.

机构信息

Fisheries College, Jimei University, Xiamen 361021, China.

Key Laboratory of Healthy Mariculture for the East China Sea, Ministry of Agriculture and Rural, Xiamen 361021, China.

出版信息

Int J Mol Sci. 2022 Dec 1;23(23):15136. doi: 10.3390/ijms232315136.

DOI:10.3390/ijms232315136
PMID:36499463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9737530/
Abstract

SARS-CoV-2 as a zoonotic virus has significantly affected daily life and social behavior since its outbreak in late 2019. The concerns over its transmission through different media directly or indirectly have evoked great attention about the survival of SARS-CoV-2 virions in the environment and its potential infection of other animals. To evaluate the risk of infection by SARS-CoV-2 and to counteract the COVID-19 disease, extensive studies have been performed to understand SARS-CoV-2 biogenesis and its pathogenesis. This review mainly focuses on the molecular architecture of SARS-CoV-2, its potential for infecting marine animals, and the prospect of drug discovery using marine natural products to combat SARS-CoV-2. The main purposes of this review are to piece together progress in SARS-CoV-2 functional genomic studies and antiviral drug development, and to raise our awareness of marine animal safety on exposure to SARS-CoV-2.

摘要

自 2019 年底爆发以来,SARS-CoV-2 作为一种人畜共患病毒,极大地影响了人们的日常生活和社会行为。人们对其通过不同媒介直接或间接传播的担忧,引起了对 SARS-CoV-2 病毒在环境中的存活及其潜在感染其他动物的极大关注。为了评估感染 SARS-CoV-2 的风险并对抗 COVID-19 疾病,已经进行了广泛的研究以了解 SARS-CoV-2 的生物发生及其发病机制。本综述主要集中在 SARS-CoV-2 的分子结构、其感染海洋动物的潜力,以及利用海洋天然产物发现药物来对抗 SARS-CoV-2 的前景。本综述的主要目的是整理 SARS-CoV-2 功能基因组研究和抗病毒药物开发的进展,并提高我们对海洋动物接触 SARS-CoV-2 时的安全意识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/7c62d4c75240/ijms-23-15136-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/90b0ead96812/ijms-23-15136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/8aca31564a0b/ijms-23-15136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/4e3499c5607c/ijms-23-15136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/7c62d4c75240/ijms-23-15136-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/90b0ead96812/ijms-23-15136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/8aca31564a0b/ijms-23-15136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/4e3499c5607c/ijms-23-15136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6c/9737530/7c62d4c75240/ijms-23-15136-g004.jpg

相似文献

1
Focus on Marine Animal Safety and Marine Bioresources in Response to the SARS-CoV-2 Crisis.关注海洋动物安全和海洋生物资源,以应对 SARS-CoV-2 危机。
Int J Mol Sci. 2022 Dec 1;23(23):15136. doi: 10.3390/ijms232315136.
2
Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.针对 SARS-CoV-2 生命周期和 COVID-19 细胞因子风暴的天然产物靶向药物发现。
Am J Chin Med. 2022;50(4):927-959. doi: 10.1142/S0192415X22500380.
3
Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.SARS-CoV-2 感染管理中潜在治疗靶点和抗病毒药物开发的方法和进展。
Eur J Pharmacol. 2020 Oct 15;885:173450. doi: 10.1016/j.ejphar.2020.173450. Epub 2020 Jul 31.
4
Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.小分子药物治疗 COVID-19 的发现:临床研究综述。
Mini Rev Med Chem. 2021;21(12):1431-1456. doi: 10.2174/1389557521666201228145755.
5
Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation.海洋天然产物的生物活性潜能来自珊瑚相关微生物和计算机模拟抗 SARS-CoV-2 评估。
Mar Drugs. 2020 Dec 16;18(12):645. doi: 10.3390/md18120645.
6
Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.具有串联抗炎、免疫调节和抗SARS-CoV/2作用的天然产物:针对SARS-CoV-2的药物发现视角
Curr Med Chem. 2022;29(14):2530-2564. doi: 10.2174/0929867328666210726094955.
7
Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview.食物植物次生代谢物的抗病毒活性及其在 SARS-CoV-2 治疗中的可能作用:综述。
Molecules. 2023 Mar 8;28(6):2470. doi: 10.3390/molecules28062470.
8
Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology.新型冠状病毒肺炎化学治疗药物研发与新技术进展
Molecules. 2022 Nov 26;27(23):8257. doi: 10.3390/molecules27238257.
9
Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.天然产物抗冠状病毒的现状:在 COVID-19 治疗和抗病毒机制方面的观点。
Curr Pharm Des. 2020;26(41):5241-5260. doi: 10.2174/1381612826666201106093912.
10
Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.天然产物作为抗 SARS-CoV 和 SARS-CoV-2 的潜在药物。
Curr Med Chem. 2021;28(27):5498-5526. doi: 10.2174/0929867328666210125113938.

引用本文的文献

1
SARS-CoV-2 RNA in Wastewater and Bivalve Mollusk Samples of Campania, Southern Italy.意大利南部坎帕尼亚地区污水和双壳贝类样本中的 SARS-CoV-2 RNA
Viruses. 2023 Aug 21;15(8):1777. doi: 10.3390/v15081777.

本文引用的文献

1
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites.关于 SARS-CoV-2 的结构蛋白、非结构蛋白和辅助蛋白的综述:突出药物靶点。
Immunobiology. 2023 Jan;228(1):152302. doi: 10.1016/j.imbio.2022.152302. Epub 2022 Nov 15.
2
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19.用于 COVID-19 的基于植物的病毒样颗粒疫苗诱导的免疫应答的持久性和交叉反应性。
Nat Commun. 2022 Nov 12;13(1):6905. doi: 10.1038/s41467-022-34728-1.
3
Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.
抑制 ACE2 的 SUMO 化通过 TOLLIP 介导的选择性自噬来抵抗 SARS-CoV-2 感染。
Nat Commun. 2022 Sep 3;13(1):5204. doi: 10.1038/s41467-022-32957-y.
4
Structure of SARS-CoV-2 membrane protein essential for virus assembly.SARS-CoV-2 膜蛋白结构对于病毒组装至关重要。
Nat Commun. 2022 Aug 5;13(1):4399. doi: 10.1038/s41467-022-32019-3.
5
Identification of Cyanobacteria-Based Natural Inhibitors Against SARS-CoV-2 Druggable Target ACE2 Using Molecular Docking Study, ADME and Toxicity Analysis.利用分子对接研究、ADME 和毒性分析鉴定基于蓝藻的针对 SARS-CoV-2 可成药靶点 ACE2 的天然抑制剂。
Indian J Clin Biochem. 2023 Jul;38(3):361-373. doi: 10.1007/s12291-022-01056-6. Epub 2022 Jul 5.
6
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.SARS-CoV-2 奥密克戎是一种具有改变的细胞进入途径的免疫逃逸变体。
Nat Microbiol. 2022 Aug;7(8):1161-1179. doi: 10.1038/s41564-022-01143-7. Epub 2022 Jul 7.
7
Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission.污水测序揭示了早期隐匿性 SARS-CoV-2 变异株的传播。
Nature. 2022 Sep;609(7925):101-108. doi: 10.1038/s41586-022-05049-6. Epub 2022 Jul 7.
8
The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白NSP2会损害人类4EHP-GIGYF2复合物的沉默能力。
iScience. 2022 Jul 15;25(7):104646. doi: 10.1016/j.isci.2022.104646. Epub 2022 Jun 20.
9
Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells.需要同时抑制液泡型 ATP 酶和 TMPRSS2 才能完全阻断 SARS-CoV-2 进入细胞。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0043922. doi: 10.1128/aac.00439-22. Epub 2022 Jun 15.
10
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation.SARS-CoV-2 从人类传播到动物以及潜在的宿主适应性。
Nat Commun. 2022 May 27;13(1):2988. doi: 10.1038/s41467-022-30698-6.